Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Rosenfeld

Showing results (1-10 of 331) with videos related to

Pageof 34
Sort By:
American Journal of Ophthalmology|March 10, 2019
Lessons Learned From Avastin and OCT-The Great, the Good, the Bad, and the Ugly: The LXXV Edward Jackson Memorial LecturePhilip J Rosenfeld
Investigative Ophthalmology & Visual Science|July 14, 2016
Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular DegenerationPhilip J Rosenfeld
Lancet (London, England)|October 30, 2007
New treatments for age-related macular degenerationPhilip J Rosenfeld
Retina (Philadelphia, Pa.)|January 25, 2012
Scientific giantPhilip J Rosenfeld
The New England Journal of Medicine|April 30, 2011
Bevacizumab versus ranibizumab for AMDPhilip J Rosenfeld
American Journal of Ophthalmology|July 4, 2006
Intravitreal avastin: the low cost alternative to lucentis?Philip J Rosenfeld
Ophthalmology|May 23, 2018
Preventing the Growth of Geographic Atrophy: An Important Therapeutic Target in Age-Related Macular DegenerationPhilip J Rosenfeld
Ophthalmic Research|August 22, 2012
Strategies for following dry age-related macular degenerationZohar Yehoshua, Philip J Rosenfeld
Developments in Ophthalmology|March 30, 2016
Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2Luiz Roisman, Philip J Rosenfeld
American Journal of Ophthalmology|January 15, 2013
Reply: To PMID 22264942Serafin Gonzalez, Philip J Rosenfeld
Pageof 34

Showing results (1-10 of 331) with videos related to

Sort By:
Pageof 34
American Journal of Ophthalmology|March 10, 2019
Lessons Learned From Avastin and OCT-The Great, the Good, the Bad, and the Ugly: The LXXV Edward Jackson Memorial LecturePhilip J Rosenfeld
Investigative Ophthalmology & Visual Science|July 14, 2016
Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular DegenerationPhilip J Rosenfeld
Lancet (London, England)|October 30, 2007
New treatments for age-related macular degenerationPhilip J Rosenfeld
Retina (Philadelphia, Pa.)|January 25, 2012
Scientific giantPhilip J Rosenfeld
The New England Journal of Medicine|April 30, 2011
Bevacizumab versus ranibizumab for AMDPhilip J Rosenfeld
American Journal of Ophthalmology|July 4, 2006
Intravitreal avastin: the low cost alternative to lucentis?Philip J Rosenfeld
Ophthalmology|May 23, 2018
Preventing the Growth of Geographic Atrophy: An Important Therapeutic Target in Age-Related Macular DegenerationPhilip J Rosenfeld
Ophthalmic Research|August 22, 2012
Strategies for following dry age-related macular degenerationZohar Yehoshua, Philip J Rosenfeld
Developments in Ophthalmology|March 30, 2016
Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2Luiz Roisman, Philip J Rosenfeld
American Journal of Ophthalmology|January 15, 2013
Reply: To PMID 22264942Serafin Gonzalez, Philip J Rosenfeld
Pageof 34